Vincristine, Ifosfamide, and Doxorubicin for Initial Treatment of Ewing Sarcoma in Adults

BACKGROUND. There are no clinical trials specifically addressing chemotherapy for adults with Ewing sarcoma (ES). Five‐year event‐free survival (EFS) of adults on pediatric studies of ES (44%–47%) is worse than that of children treated with the same therapy (69%). The object of this study was to rev...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Oncologist
Auteurs principaux: Wagner, Michael J., Gopalakrishnan, Vancheswaran, Ravi, Vinod, Livingston, J. Andrew, Conley, Anthony P., Araujo, Dejka, Somaiah, Neeta, Zarzour, Maria A., Ratan, Ravin, Wang, Wei-Lien, Patel, Shreyaskumar R., Lazar, Alexander, Ludwig, Joseph A., Benjamin, Robert S.
Format: Artigo
Langue:Inglês
Publié: AlphaMed Press 2017
Sujets:
Sarcomas
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5634776/
https://ncbi.nlm.nih.gov/pubmed/28710342
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2016-0464
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires